Pulse Biosciences Collaborates With Clayman Thyroid Center on Thyroid Nodule Treatment

MT Newswires Live10-14

Pulse Biosciences (PLSE) said Wednesday it signed a partnership with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida, to use its Npulse Vybrance device on patients and gather new data on thyroid nodule treatment.

The center has started treating patients with the device and is the only site in the Tampa Bay area for symptomatic noncancerous thyroid nodules, the company said.

Pulse Biosciences and the center will collect real-world patient outcomes and run formal studies of the treatment's use for noncancerous thyroid nodules, the company said.

The device delivers tiny bursts of electricity while using ultrasound, aiming to remove targeted cells without damaging nearby nerves and blood vessels, and patients can go home the same day, it added.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment